Combination therapies for advanced hepatocellular carcinoma: a beacon of light or a castle in the air

作     者：Vikrant Rai Sandeep Mukherjee 

作者机构：Department of Translational ResearchWestern University of Health SciencesPomonaCAUSA Department of MedicineCreighton University School of MedicineOmahaNEUSA 

出 版 物：《Hepatobiliary Surgery and Nutrition》 (肝胆外科与营养（英文）)

年 卷 期：2022年第11卷第4期

页      面：629-631页

核心收录：

学科分类：1004[医学-公共卫生与预防医学(可授医学、理学学位)] 1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学] 

主　　题：therapies hepatocellular al. 

摘      要：The review article by Zhang et al.(1)critically discussed the efficacy of combination therapies for advanced hepatocellular carcinoma(HCC)and the factors affecting efficacy and overall survival(OS)with a particular emphasis on timing and sequence of combination therapies to improve *** role of interventional therapies such as radio-frequency ablation(RFA)and chemoembolization were also discussed-although ablation is well-established for the treatment of small tumors,cancer,it may not be appropriate for tumors near the liver capsule or adjacent to blood vessels due to a higher risk of complications and local recurrence from untreated perivascular cells.